Literature DB >> 9074758

Cellular and molecular mechanisms of pulmonary vascular remodeling.

K R Stenmark1, R P Mecham.   

Abstract

In many organs and tissues, the cellular response to injury is associated with a reiteration of specific developmental processes. Studies have shown that, in response to injury, vascular wall cells in adult organisms express genes or gene products characteristic of earlier developmental states. Other genes, expressed preferentially in adult cells in vivo, are down-regulated following injurious stimuli. Complicating matters, however, are recent observations demonstrating that the vascular wall is comprised of phenotypically heterogeneous subpopulations of endothelial cells, smooth muscle cells, and fibroblasts. It is unclear how specific subsets of cells respond to injury and thus contribute to the vascular remodeling that characterizes chronic pulmonary hypertension. This review discusses vascular development in the lung and the cellular responses occurring in pulmonary hypertension; special attention is given to heterogeneity of responses within cell populations and reiteration of developmental processes.

Entities:  

Mesh:

Year:  1997        PMID: 9074758     DOI: 10.1146/annurev.physiol.59.1.89

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  90 in total

Review 1.  Primary pulmonary hypertension: the pressure rises for a gene.

Authors:  J R Thomson; R C Trembath
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

2.  Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.

Authors:  Yingfeng Wang; Wenju Lu; Kai Yang; Yan Wang; Jie Zhang; Jing Jia; Xin Yun; Lichun Tian; Yuqin Chen; Qian Jiang; Bo Zhang; Xiuqing Chen; Jian Wang
Journal:  J Mol Med (Berl)       Date:  2014-11-14       Impact factor: 4.599

3.  Endothelial differentiation by multipotent fetal mouse lung mesenchymal cells.

Authors:  Yasutoshi Yamamoto; Harold Scott Baldwin; Lawrence S Prince
Journal:  Stem Cells Dev       Date:  2011-10-18       Impact factor: 3.272

Review 4.  The applications of atomic force microscopy to vision science.

Authors:  Julie A Last; Paul Russell; Paul F Nealey; Christopher J Murphy
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-12       Impact factor: 4.799

5.  ClC-3: more than just a volume-sensitive Cl- channel.

Authors:  Carmelle V Remillard; Jason X-J Yuan
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.

Authors:  Ivana Fantozzi; Wei Huang; Jifeng Zhang; Shen Zhang; Oleksandr Platoshyn; Carmelle V Remillard; Patricia A Thistlethwaite; Jason X-J Yuan
Journal:  Exp Lung Res       Date:  2005-10       Impact factor: 2.459

7.  Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1.

Authors:  Neil J Davie; Evgenia V Gerasimovskaya; Stephen E Hofmeister; Aaron P Richman; Peter L Jones; John T Reeves; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

8.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

9.  Complementary vasoactivity and matrix remodelling in arterial adaptations to altered flow and pressure.

Authors:  A Valentín; L Cardamone; S Baek; J D Humphrey
Journal:  J R Soc Interface       Date:  2009-03-06       Impact factor: 4.118

10.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.